4.0 Article

Differential systemic exposure to galangin after oral and intravenous administration to rats

Related references

Note: Only part of the references are listed.
Review Nutrition & Dietetics

Flavonoid Bioavailability and Attempts for Bioavailability Enhancement

Surangi H. Thilakarathna et al.

NUTRIENTS (2013)

Article Pharmacology & Pharmacy

Metabolism of Quercetin In Vivo and Its Protective Effect Against Arteriosclerosis

Keisuke Ishizawa et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)

Review Pharmacology & Pharmacy

Multiple Peaking Phenomena in Pharmacokinetic Disposition

Neal M. Davies et al.

CLINICAL PHARMACOKINETICS (2010)

Review Biochemistry & Molecular Biology

Flavonols and cardiovascular disease

Francisco Perez-Vizcaino et al.

MOLECULAR ASPECTS OF MEDICINE (2010)

Review Chemistry, Multidisciplinary

The impact of flavonoids on memory: physiological and molecular considerations

Jeremy P. E. Spencer

CHEMICAL SOCIETY REVIEWS (2009)

Article Food Science & Technology

Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells

Tebekeme Okoko et al.

FOOD AND CHEMICAL TOXICOLOGY (2009)

Article Pharmacology & Pharmacy

Quercetin Glucuronide Inhibits Cell Migration and Proliferation by Platelet-Derived Growth Factor in Vascular Smooth Muscle Cells

Keisuke Ishizawa et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)

Article Pharmacology & Pharmacy

Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes

Y Otake et al.

DRUG METABOLISM AND DISPOSITION (2002)

Article Pharmacology & Pharmacy

Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9

Y Otake et al.

DRUG METABOLISM AND DISPOSITION (2002)